Enanta Pharmaceuticals
ENTA
₹593.43
Share price
-6.05%
Change (1 day)
-50.39%
Change (1 year)
Categories
Enanta Pharmaceuticals (ENTA) - Cash on Hand
Cash on Hand as of December 2024 : ₹18.82 Billion
According to Enanta Pharmaceuticals
's latest financial reports the company has ₹18.82 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Enanta Pharmaceuticals - Cash on Hand chart (from 2011 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-09-30 | ₹20.77 B | -32.47% |
| 2023-09-30 | ₹30.76 B | 51.51% |
| 2022-09-30 | ₹20.30 B | 11.98% |
| 2021-09-30 | ₹18.13 B | -36.49% |
| 2020-09-30 | ₹28.55 B | 20.81% |
| 2019-09-30 | ₹23.63 B | 5.57% |
| 2018-09-30 | ₹22.38 B | 53.26% |
| 2017-09-30 | ₹14.60 B | 4.07% |
| 2016-09-30 | ₹14.03 B | 46.65% |
| 2015-09-30 | ₹9.57 B | 71.33% |
| 2014-09-30 | ₹5.58 B | -12.49% |
| 2013-09-30 | ₹6.38 B | 176% |
| 2012-09-30 | ₹2.31 B | 102.93% |
| 2011-09-30 | ₹1.13 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | ₹482.65 B | 2,463.56% | 🇺🇸 USA |
 | ₹2.130 T | 11,216.58% | 🇺🇸 USA |
 | ₹531.38 B | 2,722.41% | 🇺🇸 USA |
 | ₹1.189 T | 6,217.29% | 🇺🇸 USA |
 | ₹943.49 B | 4,911.28% | 🇺🇸 USA |
 | ₹1.160 T | 6,061.31% | 🇨🇭 Switzerland |